Repro Med Valuation
| KRMD Stock | USD 2.95 0.03 1.03% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Repro Med Systems holds a recent Real Value of $3.54 per share. The prevailing price of the company is $2.95. Our model determines the value of Repro Med Systems from analyzing the company fundamentals such as Operating Margin of (0.18) %, shares outstanding of 45.96 M, and Return On Equity of -0.33 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Repro Med's valuation include:
Price Book 7.9266 | Enterprise Value | Enterprise Value Ebitda (17.15) | Price Sales 3.9884 | Forward PE 188.6792 |
Undervalued
Today
Please note that Repro Med's price fluctuation is unstable at this time. Calculation of the real value of Repro Med Systems is based on 3 months time horizon. Increasing Repro Med's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Repro stock is determined by what a typical buyer is willing to pay for full or partial control of Repro Med Systems. Since Repro Med is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Repro Stock. However, Repro Med's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.95 | Real 3.54 | Target 4.9 | Hype 2.89 | Naive 3.37 |
The real value of Repro Stock, also known as its intrinsic value, is the underlying worth of Repro Med Systems Company, which is reflected in its stock price. It is based on Repro Med's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Repro Med's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Repro Med Systems helps investors to forecast how Repro stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Repro Med more accurately as focusing exclusively on Repro Med's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Repro Med's intrinsic value based on its ongoing forecasts of Repro Med's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Repro Med's closest peers. If more than one evaluation category is relevant for Repro Med we suggest using both methods to arrive at a better estimate.
Repro Med Cash |
|
Repro Valuation Trend
Comparing Repro Med's enterprise value against its market capitalization is a good way to estimate the value of Repro Med Systems uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Repro Med Total Value Analysis
Repro Med Systems is now expected to have valuation of 127.68 M with market capitalization of 134.19 M, debt of 3.72 M, and cash on hands of 18.27 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Repro Med fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
127.68 M | 134.19 M | 3.72 M | 18.27 M |
Repro Med Investor Information
About 51.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.13. Repro Med Systems had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Repro Med's historical financial statements, Repro Med Systems is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Repro Med Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Repro Med has an asset utilization ratio of 123.62 percent. This indicates that the Company is making $1.24 for each dollar of assets. An increasing asset utilization means that Repro Med Systems is more efficient with each dollar of assets it utilizes for everyday operations.Repro Med Ownership Allocation
Repro Med owns a total of 45.96 Million outstanding shares. Over half of Repro Med's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Repro Med Profitability Analysis
The company reported the previous year's revenue of 33.65 M. Net Loss for the year was (6.07 M) with profit before overhead, payroll, taxes, and interest of 21.33 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Repro Med's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Repro Med and how it compares across the competition.
About Repro Med Valuation
The stock valuation mechanism determines Repro Med's current worth on a weekly basis. Our valuation model uses a comparative analysis of Repro Med. We calculate exposure to Repro Med's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Repro Med's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 21.3 M | 22.4 M | |
| Pretax Profit Margin | (0.18) | (0.17) | |
| Operating Profit Margin | (0.17) | (0.16) | |
| Net Loss | (0.18) | (0.17) | |
| Gross Profit Margin | 0.63 | 0.46 |
Repro Med Growth Indicators
Investing in growth stocks can be very risky. If the company such as Repro Med does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 45.8 M | |
| Quarterly Earnings Growth Y O Y | -0.66 | |
| Forward Price Earnings | 188.6792 |
Repro Med Current Valuation Indicators
Valuation refers to the process of determining the present value of Repro Med Systems and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Repro we look at many different elements of the entity such as Repro's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Repro Med, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Repro Med's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Repro Med's worth.Complementary Tools for Repro Stock analysis
When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |